We deliver market intelligence combining stock research, financial news, and earnings summaries to support data-driven investment decisions.
NovaBay Pharmaceuticals Inc. (NBY) is a specialty pharmaceutical company trading at a current price of $1.95 as of 2026-04-13, marking a 22.64% gain in recent trading activity. This analysis covers key technical levels to monitor for NBY, prevailing market context for the small-cap biotech sector, and potential near-term price scenarios based on current market data. No recent earnings data is available for the company as of the current date, so this analysis focuses primarily on technical and se
What accelerates growth of NovaBay Pharmaceuticals (NBY) Stock | Price at $1.95, Up 22.64% - Backspread Trade
NBY - Stock Analysis
4059 Comments
1044 Likes
1
Lozell
Elite Member
2 hours ago
{协议答案}
👍 42
Reply
2
Dagger
Loyal User
5 hours ago
{协议答案}
👍 270
Reply
3
Courtnay
Legendary User
1 day ago
{协议答案}
👍 85
Reply
4
Dolorse
Experienced Member
1 day ago
{协议答案}
👍 171
Reply
5
Triena
Regular Reader
2 days ago
{协议答案}
👍 87
Reply
Disclaimer: Not investment advice. For informational purposes only. Past performance does not guarantee future results. Trading involves substantial risk of loss.